Introduction
Red blood cell (RBC) destruction, or hemolysis, leads to the release of hemoglobin (Hb) into the plasma. Once in the plasma, cell-free hemoglobin (CFHb) is usually neutralized into less toxic metabolites by specialized scavenger proteins, such as haptoglobin and hemopexin.
1,2 However, after procedures such as mismatched transfusions and hemodialysis, and in some diseases, including malaria, sepsis, and hemolytic anemias (sickle cell disease [SCD] and paroxysmal nocturnal hemoglobinuria, for example), levels of intravascular Hb can become excessive.
3-5
Consequences of augmented CFHb include increased vascular nitric oxide (NO) consumption, oxidative stress, endothelial activation, and cytokine upregulation, 3,6-9 all of which contribute significantly to the pathophysiology of these disorders. Endothelial activation leads to the expression of surface adhesion molecules, which can result in the recruitment of leukocytes and platelets, increasing inflammatory processes. 10 In SCD, such leukocyte recruitment is significant as the adhesion of white and red cells to the vascular wall can trigger vaso-occlusive processes. Furthermore, once oxidized, hemoglobin releases hemin, a hydrophobic molecule recently demonstrated to induce neutrophil extracellular trap (NET) production, 11 and cause toll-like receptor (TLR)-4-mediated stasis in murine SCD. 12 As such, hemolysis constitutes a major disease mechanism, and failure to neutralize CFHb can cause vascular and organ dysfunction, leading to the adverse clinical effects that have been associated with hemolytic diseases, including leg ulcers, pulmonary hypertension and priapism.
13
Hydroxyurea (HU) is a cytostatic drug, frequently used in the treatment of hematological diseases such as SCD, beta thalassemia, polycythemia vera, essential thrombocytemia and myelofibrosis, as well as non-hematological diseases, including HIV/AIDS. [14] [15] [16] In SCD, HU modifies the disease process, improving hematological parameters and reducing hospitalization and mortality. 17 One of the major mechanisms
For personal use only. on April 19, 2017 . by guest www.bloodjournal.org From of action of HU in SCD is believed to be its ability to induce the production of fetal Hb (HbF) in erythrocytes, reducing HbS polymerization and red cell sickling. 18, 19 However, it is becoming increasingly clear that HU also has immediate benefits that can be observed in SCD before elevations in HbF occur; such alterations include reductions in leukocyte counts and improved blood flow due to local vasodilation. [20] [21] [22] A possible explanation for the acute effects of HU lies in its NO donor property, where previous reports have suggested that intravascular generation of NO occurs in SCD individuals following HU administration. [23] [24] [25] NO, in turn, facilitates vasodilatation via activation of intracellular cyclic guanosine monophosphate (cGMP) signaling in smooth muscle cells and can reduce endothelial and leukocyte activation. 20, 26, 27 In a recent study, we
reported that HU has immediate and acute beneficial effects in a murine sickle cell model (BERK) of inflammatory vaso-occlusion, reducing leukocyte adhesion recruitment and secondary red cell interactions, particularly when administered together with a cGMP-amplifying agent.
28
The aim of the current study was to observe the acute inflammatory effects of hemolytic processes in C57BL/6 mice, and to compare these to inflammatory processes observed in chimeric SCD mice. Our data suggest that, in addition to its other well-documented effects, 8 depletion of vascular NO by CFHb may contribute to the inflammatory effects of hemolysis. In addition, the abilities of a NO donor, diethylamine NONOate (DEANO), and a single-dose administration of HU to diminish hemolysis-induced inflammation were verified, as was the participation of NO/cGMPdependent mechanisms in these effects.
Methods

Animals
C57BL/6 mice and chimeric SCD mice (generated from the transplantation of bone marrow from HbSS BERK SCD mice into lethally-irradiated male C57BL/6 mice) were
For personal use only. on April 19, 2017 . by guest www.bloodjournal.org From used in the study. 28, 29 For further information about animals, their diets, housing, transplantation and confirmation of human globin expression, please see Supplementary Information. All animal procedures were carried out in accordance with the 'Principles of Laboratory Animal Care' (http://grants.nih.gov/grants/guide/noticefiles/not96-208.html), and in accordance with current Brazilian laws for the protection of animals; this study was approved by the Commission for Ethics in Animal
Experimentation of the University of Campinas (CEUA/Unicamp, protocol 2360-1). 
Hemolysis protocol and mouse treatments
In Vivo Imaging System (IVIS) protocol
For personal use only. on April 19, 2017. by guest www.bloodjournal.org From A chemiluminescent probe (XenoLight Rediject Inflammation Probe; Perkin Elmer, MA) was used to evaluate in vivo myeloperoxidase (MPO) activity. Mice were pretreated with TNF-α, H 2 O, HU, DEANO, saline or vehicle and then anesthetized in a plastic chamber (2.5% isofluorane/oxygen). The probe (200 mg/kg) was then injected (i.v.) immediately before image capture (5 min exposure) and luminescent detection, using an IVIS Lumina System ® (Caliper LifeSciences, MA). Isofluorane anesthesia (1.5%) was maintained during IVIS procedures. Signal intensity was quantified as the photon flux (photons per second) within the region of interest using IVIS Living Image 3.0 software (Caliper LifeSciences).
Plasma hemoglobin and nitrate quantification
Plasma was stored at -80 o C for CFHb quantification using the Fairbanks AII method, as described. 31 Samples were centrifuged (1 200g, 10 min) before quantification and Hb concentrations are expressed as µM heme associated with Hb, assuming Hb to be tetramic. Plasma nitrate was quantified using a nitrate/nitrite colorimetric assay (Cayman Chemical Company, Ann Arbor, MI).
Intravital microscopy
After treatment protocols, mice were anesthetized (2% 
Neutrophil isolation, incubation with RBC lysate and adhesion assays
For information regarding in vitro neutrophil assays, please see Supplementary Information.
Statistical Analyses
Statistical analyses are described in Supplementary Information.
Results
Intravenous administration of water induces rapid hemolysis in C57BL/6 mice Under basal conditions, or at 15-min post saline administration (i.v.), C57BL/6 mice present low-level intravascular hemolysis, as evaluated by determining plasma CFHb ( Figure 1A ). In contrast, basal hemolysis was approximately 2.5-fold higher in chimeric SCD mice. Intravenous injection of sterile H 2 O (150 μ l) induces a marked increase in CFHb within just 15 min in C57BL/6 mice ( Figure 1B) , resulting in similar levels of CFHb to those of non-manipulated chimeric SCD mice ( Figure 1A ). In contrast, sterile H 2 O injection does not induce further hemolysis in chimeric SCD mice within 60 min ( Figure 1B ). Intraperitoneal administration of neither the pro-inflammatory cytokine, TNF-α (0.5 µg; Figure 1C ), nor hemin (40 µmols/kg; Figure 1D ) was able to elevate plasma CFHb levels in either C57BL/6 mice or chimeric SCD mice, within 180 and 120 minutes, respectively. Hemolysis induces extensive systemic inflammation in C57BL/6 mice, comparable to that of TNF-α cytokine administration C57BL/6 mice received hemolytic or inflammatory stimuli, and systemic inflammation was quantified using a probe to detect MPO in activated neutrophils using in vivo imaging. Rapid hemolysis, induced by H 2 O administration, was accompanied by extensive inflammation that was comparable to that induced by the intraperitoneal administration of the inflammatory cytokine, TNF-α (Figure 2A-B) . Inflammation, induced by both H 2 O and TNF-α, was observed in the entire body of the C57BL/6 mice, with a greater dissemination in the abdominal/peritoneal area. In contrast, the administrations of similar volumes of a vehicle solution or of saline were unable to produce inflammation. Interestingly, basal inflammation in chimeric SCD mice ( Figure   2C -D) was found to be significantly higher than that of the basal inflammation of C57BL/6 mice, demonstrating levels that were similar to those of hemolysis-induced C57BL/6 mice. Intraperitoneal administration of TNF-α induced a further and significant systemic inflammatory response in these chimeric SCD mice ( Figure 2C-D) ; however, the intravenous injection of H 2 O in chimeric SCD mice did not result in any further increase in inflammation, in keeping with the finding that this approach does not generate further hemolysis in chimeric SCD mice ( Figure 2C-D) .
Rapid hemolysis induces vascular leukocyte recruitment in C57BL/6 mice, comparable to that of TNF-α administration
We then looked at the effects of H 2 O-induced rapid hemolysis on leukocyte dynamics in the microcirculation of C57BL/6 mice, using intravital microscopy. Previous studies [32] [33] [34] have comprehensively shown the effects of inflammatory stimuli on the induction of leukocyte adhesion to the microvasculature. In BERK SCD mice, inflammatory stimuli lead to leukocyte recruitment, followed by secondary red cell capture and eventually For personal use only. on April 19, 2017. by guest www.bloodjournal.org From vaso-occlusive processes. 28, 29, 35 In C57BL/6 mice, as expected, at 3-h post-TNF-α administration (0.5 µg; i.p.), leukocytes demonstrate decreased rolling and markedly increased adhesion to the microvasculature vessels walls, as well as augmented extravasation (Figure 3) . Surprisingly, intravenous administration of H 2 O in C57BL/6 mice, with ensuing hemolysis, caused a significant decrease in leukocyte rolling and increased leukocyte adhesion to the microvascular walls ( Figure 3A-B) , within 15 min.
These effects were similar in magnitude to those of the TNF-α inflammatory stimulus. 
Hydroxyurea reduces hemolysis-induced inflammation via a nitric oxidedependent pathway
Hypothesizing that the acute beneficial effects of HU upon hemolytic inflammatory processes are due to NO release in vivo and/or stimulation of cGMP-dependent signaling, we administered H 2 O (i.v.) in C57BL/6 mice together with HU and the NO scavenger PTIO or ODQ (a sGC inhibitor). Figure 6 demonstrates that both PTIO and ODQ abrogate the beneficial effects of HU on WBC rolling, adhesion and extravasation.
Effects of hemoglobin on endothelial cells can be partially inhibited by hydroxyurea
Given that CFHb may exert some of its inflammatory effects via endothelial activation, we looked at the effect of the inhibition of endothelial adhesion molecules on H 2 O- 
Induction of neutrophil adhesion by RBC lysates is partially prevented by hydroxyurea
Neutrophils from healthy individuals were isolated and incubated with autologous RBC lysate (1.5 mg/ml Hb) in the presence or absence of HU (100 µM), and their capacity to adhere to ICAM-1 was evaluated using two assays; a static adhesion assay (5 min incubation with RBC lysate; Figure 7G ) and a microfluidic adhesion assay (4 h incubation with RBC lysate; Figure 7H ). After 4 h of incubation with RBC lysate, the adhesive properties of human neutrophils were significantly increased, while at 5 min this increase was not significant. The presence of HU in cultures significantly diminished these RBC lysate-induced neutrophil adhesive properties.
Discussion
Under normal conditions, Hb is compartmentalized inside erythrocytes, where its primary function is to transport oxygen throughout the organism; however, under certain circumstances, and in a number of diseases, such as SCD, the erythrocyte New insights into the potent inflammatory effects of hemolytic products have emerged following reports that heme activates inflammasome formation in macrophages, 38 and induces NET release in neutrophils of BERK SCD mice, as well as TLR-4-mediated signaling in endothelial cells. 11, 12 In support of these data, we induced intravascular hemolysis in C57BL/6 mice, elevating CFHb to levels equivalent to those of a chimeric SCD mouse model (approximately 2.5-fold higher); in vivo imaging demonstrated that this hemolysis was associated with a rapid generation of systemic inflammation that was similar to the inflammation observed in TNF-α-stimulated mice and in non-manipulated chimeric SCD mice. Furthermore, intravital microscopy showed that intravenous H 2 O-induced hemolysis in C57BL/6 mice was associated with augmented leukocyte recruitment in venules, similar to that observed in TNF-α-stimulated C57BL/6 mice, and previously reported to trigger vaso-occlusive events in 
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